003060.KS
Aprogen Biologics Inc.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 1,727.00
−0.86%Margins
Gross margin
-27.1%
EBITDA margin
-32.2%
EBIT margin
-137.7%
Net margin
-90.9%
FCF margin
-41.9%
-40.3%
Return on equity
-14.3%
Return on assets
-29.3%
Return on invested capital
0.15x
Asset turnover
-KRW 32.3B
Cash from operations
KRW 1.7K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026